InsiderClue
Insiders · Profile

Lundbeckfond Invest A/S

10% owner at Lexeo Therapeutics · 10% owner at Enliven Therapeutics · 10% owner at Trevi Therapeutics. Filing since 9 May 2019. CIK 0001591046

LXEO Lexeo Therapeutics, Inc. 10% owner · 1 trade ELVN Enliven Therapeutics, Inc. 10% owner · 1 trade TRVI Trevi Therapeutics, Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
LXEO Lexeo Therapeutics, Inc.
7 Nov 2023
10% owner
Bought
227,272
$2.50M
14.1%
ELVN Enliven Therapeutics, Inc.
16 Mar 2020
10% owner
Bought
187,500
$3.00M
15.1%
TRVI Trevi Therapeutics, Inc.
9 May 2019
10% owner
Bought
375,000
$3.75M
48.3%
3 decisions on file.